Company intelligence / Profile preview

US Cancer Management Corporation

California, United States

Ownership: Private
Development stage: Other

Overview

US Cancer Management Corporation is a private healthcare management company focused on developing and operating comprehensive cancer centers in the United States. Rather than functioning as a drug developer, the company provides radiation oncology and related cancer-care services through strategic partnership centers. Its offerings include center development and optimization, accreditation consulting, and remote dosimetry services for radiation oncology providers. The company appears to operate an established commercial network of community-based cancer centers, with a particular emphasis on radiation and surgical oncology.

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on US Cancer Management Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on US Cancer Management Corporation.

Explore the full profile